Overview
SYNTHOMER
Synthomer is a leading supplier of high-performance, highly specialized polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets that serve billions of end users worldwide. From its innovation centers of excellence and manufacturing sites across Europe, North America and Asia, it collaborates closely with its customers to develop new products and enhance existing
...
Read More ones tailored to their needs, with an increasing range of sustainability benefits. And through its focus on making its business more efficient, more global and even more specialized, Synthomer is positioned to lead the way as a speciality business whose products enhance people's homes and cities, lifestyles, transportation and healthcare. About 5% of the company's total revenue comes from outside UK. Synthomer was established in 1863 as George Yule & Co.
Read Less
Read More ones tailored to their needs, with an increasing range of sustainability benefits. And through its focus on making its business more efficient, more global and even more specialized, Synthomer is positioned to lead the way as a speciality business whose products enhance people's homes and cities, lifestyles, transportation and healthcare. About 5% of the company's total revenue comes from outside UK. Synthomer was established in 1863 as George Yule & Co.
Read Less
Alexander Gordon Catto
See more contacts
Management of Companies and Enterprises
,
Holding companies, nec
?
?
Estimated
$2.52 billion
Actual
2.38%
$2,537
DEC
?
?
London SETS:SYNT
Contacts
Get in Touch with 11 Principals* and 88 Contacts
-
Alexander Gordon CattoDirector and Non-Executive Director
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$2.52 billion
USD
Actual
1 USD = 0.7888 GBP
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | -$42 | $190 | $170 |
| Net Investing Cash | -$78 | $137 | -$1,075 |
| Net Financing Cash | -$58 | -$115 | $525 |
| Net Change in Cash | -$179 | $211 | -$380 |
| Cash at Beginning of Period | $470 | $265 | $641 |
| Cash at End of Period | $286 | $470 | $265 |
| Capital Expenditure | -$115 | -$106 | -$115 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $286 | $471 | $289 |
| Accounts Receivable | $198 | $187 | $255 |
| Inventories | $441 | $436 | $517 |
| Other Current Assets | $122 | $111 | $415 |
| Asset Summary | |||
| Total Current Assets | $1,047 | $1,205 | $1,476 |
| Tangible Fixed Assets | $873 | $895 | $955 |
| Intangible Assets | $606 | $664 | $741 |
| Total Assets | $2,537 | $2,707 | $3,048 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $332 | $345 | $322 |
| Short-Term Debt | $157 | $1 | $23 |
| Other Current Liabilities | $214 | $273 | $394 |
| Liability Summary | |||
| Total Current Liabilities | $704 | $619 | $739 |
| Long-Term Debt | $886 | $1,103 | $1,564 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $1,812 | $1,958 | $2,556 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $2 | $2 | $59 |
| Retained Earnings | $173 | $266 | $347 |
| Equity Summary | |||
| Total Equity | $1,385 | $1,456 | $1,289 |
| Shares Outstanding | 163,471,105 | 163,566,913 | 63,434,954 |